Expression of Epstein-Barr virus nuclear antigens in anti-IgM-stimulated B cells following recombinant vaccinia infection and their recognition by human cytotoxic T cells.
Rajiv Khanna(QIMR Berghofer Medical Research Institute), Denis J. Moss(The University of Queensland), Scott R. Burrows(Australian National University), T B Sculley(QIMR Berghofer Medical Research Institute), Catherine Jacob(QIMR Berghofer Medical Research Institute), I S Misko(QIMR Berghofer Medical Research Institute), Elliott Kieff(Brigham and Women's Hospital), Michael G. Kurilla(QIMR Berghofer Medical Research Institute)
PubMed
November 1, 1991
Cited by 35
Related Papers
Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.
|The Journal of Experimental Medicine|1992|391
Epstein–Barr virus latent genes
|Experimental & Molecular Medicine|2015|362
Activation and adoptive transfer of Epstein–Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease
|Proceedings of the National Academy of Sciences|1999|332